A ‘life-extending’ cancer drug is set to be offered to thousands more patients on the NHS across the country.
As the health service looks to widen the access to treatment nationwide, the prostate cancer drug – known as abiraterone – will be offered to thousands of men whose cancer has not spread in the coming weeks, following the clinical advice to roll it out last year.
Around 2,000 men have been diagnosed with prostate cancer in the last three months, and an additional 7,000 men are expected to be diagnosed each year – all of whom will be eligible for the drug.
The drug works to stop the cancer spreading by starving the disease of the hormones it needs to grow, such as testosterone.
Research has shown that for these earlier stage patients, the survival rate after six years is improved – with trials showing that the proportion of men alive after six years on abiraterone was 86%, compared to 77% on standard treatment (hormone therapy, with or without radiotherapy).
ADVERTISEMENT
Thousands of men with prostate cancer in England will be offered a life-extending drug on the NHS.
Patients with prostate cancer that has not spread will be able to receive abiraterone on the NHS if it is of clinical benefit.
The NHS has worked with campaigners, including Prostate Cancer UK, to secure the rollout of this drug.
In the past five years alone, the NHS in England has also commissioned new innovative targeted prostate cancer therapies – including branded drugs like enzalutamide, darolutamide, relugolix and apalutamide.
ADVERTISEMENT
“For thousands of men with prostate cancer, this treatment option could be life-changing by helping keep their cancer at bay for several years,” explained Professor Peter Johnson, who is the National Clinical Director for Cancer at NHS England.
“The life-extending treatment available on the NHS within weeks will mean thousands of men can kick-start their year with the news that they will have a better chance of living longer and healthier lives.
“The NHS will continue to work hard to offer people the most effective and evidence-based treatments, with several new prostate cancer drugs rolled over the last five years.”
Featured Image – Ksenia Yakovleva (via Unsplash)
News
One million UK adults who have never smoked before are now vaping, new stats reveal
Emily Sergeant
More than a million UK adults who claim to have never smoked cigarettes are now vaping.
According to alarming new data from the Office for National Statistics (ONS), relating to people aged 16 and over, around 2.8 million men (11.3%) and 2.1 million women (8.2%) are thought to be smokers in the UK… but more than a million people, who have never smoked before, have now made the decision to start vaping instead.
People in the 25 to 34 age group were found to be the most likely to vape, according to the data, overtaking those aged 16 to 24, as it was the only age group to see a rise in e-cigarette usage.
Daily or occasional vaping is still higher than the proportion of people smoking cigarettes too, the ONS revealed, at 5.4 million, or 9.9%, versus 4.8 million (8.7%).
One million UK adults who have never smoked are now vaping / Credit: Lil Artsy (via Pexels) | Pxhere
“Fewer than one in 10 adults now smoke,” commented David Mais, from the ONS.
“This is the lowest proportion on record and continues the long-term decline in smoking. [But] at the same time, e-cigarette use remains more common than smoking and has followed an overall upward trend since 2020.
“E-cigarette users are also getting older, with those aged 25 to 34 now overtaking 16 to 24-year-olds as the age group most likely to use them.
“This may reflect existing users getting older, growing popularity among this age group, or a combination of both.”
Overall, the prevalence of smoking dropped in all four UK nations between 2024 and 2025.
Featured Image – Elsa Olofsson (via Unsplash)
News
Three Manchester motorways named in UK’s top 10 ‘most challenging’
Emily Sergeant
Three motorways in and around Manchester have been named the ‘most challenging’ in the UK.
As part of MoneySuperMarket’s new Great British Motorway Report, new research has found that one in three UK motorists find motorway driving ‘stressful’ – despite more than 70 billion miles being travelled on Britain’s motorways each year.
From delays and congestion to high traffic levels, there are a number of factors that can contribute to driver stress levels.
But are some motorways more challenging for drivers than others? According to the data, yes. And three of the top 10 worst motorways in the UK are in and around Greater Manchester.
To find out which are the most challenging, MoneySuperMarket analysed everything from collision rates and roadworks, to lane closures and driver feedback in order to reveal the top 10.
Manchester is home to three of the UK’s top 10 most challenging motorways – the M602, M62, and M60, the latter of which took the top spot on the list.
Three Manchester motorways have been named in the UK’s top 10 ‘most challenging’ / Credit: pxfuel
Encircling Greater Manchester and linking many of the region’s motorways, the M60 recorded the lowest overall score in the index.
Despite handling significant volumes of traffic, the M60 experienced some of the highest average delays, at 15.58 seconds per vehicle per mile, and alongside this, it saw 34 collisions in the past year alone. But despite these challenges, the M60 remains an essential route for regional connectivity, and often cannot be bypassed.
“If you’re feeling anxious, allow extra time for your journey so you don’t feel pressured to rush or make last-minute decisions,” commented Alicia Hempsted at MoneySuperMarket.
“Plan your route in advance, including where you’ll stop for breaks, as regular rest stops can help you stay alert and reduce stress on longer trips, and if you’re travelling alone, consider sharing your route with someone you trust if it helps you feel more comfortable.”